Sydney Jennings

Physicians may know how patients can reduce their risk of exposure to coronavirus, but what about their own risk? These CDC-recommended steps offer guidance. 

Sample: Approximately what percentage of physician office visits at which benzodiazepines were coprescribed with opioids were with a primary care provider?

Over 70% of US adults with diabetes have hypertension, 15.6% of these patients have an A1c value >9%, and more fast facts on diabetes risk factors and patient characteristics.

Of the 41% of kratom users who reported taking it for opioid withdrawal, 35% went >1 year without taking opioids or heroin.

From 2013-2016, about 46% of US adults had hypertension. Plus more highlights from the AHA's annual Heart Disease and Stroke Statistical Update. 

The first and only drug to treat peanut allergy recently received approval, giving the growing number of patients a new treatment option.

Over half of coprescriptions were among general or family practice physicians and 40% among internal medicine physicians, a new CDC report suggests. 

In 2018, 9 states reported an adult obesity prevalence of ≥35%. Find out more trends from the CDCs annual Adult Obesity Prevalence Maps.

Sample: Approximately how many alcohol-related deaths were recorded between 1999-2017 among people aged ≥16 years?

The FDA is urging physicians to weigh the benefits and risks of the obesity drug, Belviq™ (lorcaserin), when deciding to start or continue treatment.

A new review found >2 million US adults with heart disease have either used marijuana in the past or are current users. 

When compared to standard diet and exercise, a new review found metformin more effective in type 2 diabetes prevention. 

How many young adults in the US actually receive their recommended doses of HPV vaccine? Take this 7-question quiz on a new report to learn more about the trends.

This month, the CDC released new recommendations for providing quality STD care in primary care clinics. Get the key points in our quick slideshow.

More young adults in the US are getting vaccinated against human papillomavirus, rising almost 50% in 5 years, according to a new report.

Two first-in-class migraine drugs, the first generic version of NuvaRing®, and 7 more fourth quarter FDA-approved drugs for primary care.

Seasonal flu activity in the US significantly increased during the final week of 2019 and is expected to keep rising.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.

The FDA has approved the first oral CGRP receptor antagonist in pill form for the acute treatment of migraine with or without aura in adults.

From healthy eating patterns to keeping that feast safe to eat, offer patients these 8 tips to kick off a healthier holiday season.

These 6 recommendations from the CDC can aid physicians in differential diagnosis and treatment of EVALI and the flu. 

Sample: What tobacco product was most commonly used among US adults in 2018? E-cigarettes? Traditional cigarettes? Neither? The answer may surprise.

Researchers of the new study being presented at the upcoming AHA 2019 Scientific Sessions highlight key inequalities related to disparities in the vaccination rates. 

A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease. 

Two studies to be presented at the upcoming AHA annual meeting found that young cannabis users are at greater risk for stroke and arrhythmia. 

From nut consumption to abnormal bowel habits, test your knowledge of the latest research in obesity with this quick quiz. 

In a new study of >600 000 Israeli adolescents, researchers found an inverse relationship between body mass index and acne. 

Type 1 diabetes patients who used the new system increased by 2.6 hours/day the amount of time spent in target blood glucose level range. 

The multistate outbreak of vaping-related lung injury is ongoing, but the CDC's updated interim guidance can help physicians navigate the clinical evaluation and management of these patients. 

Trikafta™ is the first triple combination therapy approved for the treatment of the most common cystic fibrosis mutation.